Literature DB >> 571570

Reversible alexia, mitochondrial myopathy, and lactic acidemia.

R R Skoglund.   

Abstract

A 11-year-old boy of short stature had recurrent right temporal pounding headaches of 7 months' duration, and progressive visual loss for 3 days. There was a left hemianopia, alexia without agraphia, and diffuse muscle weakness. Investigation established the presence of a mitochondrial myopathy with pyruvate and lactic acidemia and increased serum content of sarcoplasmic enzymes. On treatment with prednisone, the patient's strength and reading skill improved, symptoms resolved, and muscle enzymes returned to normal. Three attempts to reduce steroids resulted in accentuation of symptoms, seizures, weakness, regression of reading skills, and elevation of serum enzymes. The alexia was also reversible.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 571570     DOI: 10.1212/wnl.29.5.717

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Glucocorticoids for mitochondrial disorders.

Authors:  Josef Finsterer; Marlies Frank
Journal:  Singapore Med J       Date:  2015-02       Impact factor: 1.858

Review 2.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  Computed tomography and angiography in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes); report of 3 cases.

Authors:  K Hasuo; S Tamura; K Yasumori; A Uchino; S Goda; S Ishimoto; K Kamikaseda; Y Wakuta; M Kishi; K Masuda
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

4.  Biochemical studies in mitochondrial encephalomyopathy.

Authors:  S Goda; S Ishimoto; I Goto; Y Kuroiwa; K Koike; M Koike; M Nakagawa; H Reichmann; S DiMauro
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-10       Impact factor: 10.154

5.  Multiple sclerosis and mitochondrial myopathy: an unusual combination of diseases.

Authors:  L Bet; M Moggio; G P Comi; C Mariani; A Prelle; N Checcarelli; A Bordoni; N Bresolin; E Scarpini; G Scarlato
Journal:  J Neurol       Date:  1994-07       Impact factor: 4.849

6.  Clinical improvement after administration of coenzyme Q10 in a patient with mitochondrial encephalomyopathy.

Authors:  S Goda; T Hamada; S Ishimoto; T Kobayashi; I Goto; Y Kuroiwa
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

Review 7.  The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence.

Authors:  Allison Hanaford; Simon C Johnson
Journal:  Orphanet J Rare Dis       Date:  2022-09-02       Impact factor: 4.303

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.